DNAlytics

Chemin Du Cyclotron 6

1348 Ottignies-Louvain-La-Neuve

BE

DNAlytics

Foundation date

03/04/2012

Sector

#Biotechnology / R&D Services

Subsector

DNAlytics bases its activity on a Data Mining platform that it applies to develop personalized medicine solutions, from R&D to market access: diagnostic, prognostic and treatment response prediction, coupled with biomarker identification. DNAlytics has two main offers based on this technology platform: an expert consulting activity for pharmaceutical, biotech or IVD companies, and a product pipeline development. Its 1st product is RheumaKit, an early diagnostic solution for undifferentiated arthritis.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    6 hours ago

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022